Literature DB >> 31563759

Pharmacokinetic comparative study of tetramethylpyrazine and ferulic acid and their compatibility with different concentration of gastrodin and gastrodigenin on blood-stasis migraine model by blood-brain microdialysis method.

Yahui Mi1, Siyu Guo1, Huan Cheng1, Mingping Liu2, Pinqing Wei3, Meijing Wang1, Yukang Mao1, Guohan Ke1.   

Abstract

Tianma pills, a traditional formula made from Ligusticum chuanxiong and Gastrodia elata, are efficacious for the treatment of primary headache. Tetramethylpyrazine (TMP) and Ferulic acid (FA) are the bioactive ingredients of Ligusticum chuanxiong, while Gastrodin and Gastrodigenin are the bioactive ingredients of Gastrodia elata. Pharmacokinetic assessment of TMP, FA, gastrodin or gastrodigenin in blood or brain interstitial fluid (BIF) has been reported in healthy animals. However, the pharmacokinetic properties of TMP and FA have not been studied when they are co-administered in a blood-stasis migraine model. The present research investigated the pharmacokinetic behavior of TMP and FA after oral administration in the presence of different concentrations of gastrodin and gastrodigenin in a blood-stasis migraine model. Pharmacokinetic parameters were determined using blood-brain microdialysis in combination with the UHPLC-MS method. Compared to the control group, in which TMP and FA were administrated without gastrodin or gastrodigenin, the T1/2, MRT, Cmax and AUC0-∞ of TMP and FA were increased. These results indicate that varying concentrations of gastrodin and gastrodigenin play an important role in affecting the pharmacokinetics of TMP and FA. Low concentrations of gastrodin and gastrodigenin (similar to those found in Tianma pills) were more efficacious, validating the utility of the ancient formulation.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ferulic acid; Gastrodia; Gastrodigenin; Migraine; Pharmacokinetic; Tetramethylpyrazine

Mesh:

Substances:

Year:  2019        PMID: 31563759     DOI: 10.1016/j.jpba.2019.112885

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  8 in total

1.  Exploring the Scientific Rationality of the Phenomenon of "Different Dosage Forms of the Same Prescription" of Chinese Proprietary Medicine Based on Biopharmaceutical Properties of Powder and Pill of Chuanxiong Chatiao Prescription.

Authors:  Zhong-Huan Qu; Lin Liu; Xiao-Fei Zhang; Dong-Yan Guo; Bing-Tao Zhai; Jun-Bo Zou; Ya-Jun Shi
Journal:  Front Pharmacol       Date:  2022-06-09       Impact factor: 5.988

2.  Hejie Zhitong prescription promotes sleep and inhibits nociceptive transmission-associated neurotransmitter activity in a rodent migraine model.

Authors:  Xinna Wang; Hongfei Zhao; Liming Liu; Ping Niu; Chao Zhai; Jinjian Li; Qiaoli Xu; Dexi Zhao
Journal:  Chin Med       Date:  2020-09-29       Impact factor: 5.455

3.  Detecting Key Functional Components Group and Speculating the Potential Mechanism of Xiao-Xu-Ming Decoction in Treating Stroke.

Authors:  Yu-Peng Chen; Ke-Xin Wang; Jie-Qi Cai; Yi Li; Hai-Lang Yu; Qi Wu; Wei Meng; Han-Duo Wang; Chuan-Hui Yin; Jie Wu; Mian-Bo Huang; Rong Li; Dao-Gang Guan
Journal:  Front Cell Dev Biol       Date:  2022-05-12

4.  Qualitative Phytochemical Fingerprint and Network Pharmacology Investigation of Achyranthes aspera Linn. Extracts.

Authors:  Kouadio Ibrahime Sinan; Gokhan Zengin; Dimitrina Zheleva-Dimitrova; Ouattara Katinan Etienne; Mohamad Fawzi Mahomoodally; Abdelhakim Bouyahya; Devina Lobine; Annalisa Chiavaroli; Claudio Ferrante; Luigi Menghini; Lucia Recinella; Luigi Brunetti; Sheila Leone; Giustino Orlando
Journal:  Molecules       Date:  2020-04-23       Impact factor: 4.411

5.  TAT-modified serum albumin nanoparticles for sustained-release of tetramethylpyrazine and improved targeting to spinal cord injury.

Authors:  Yan Lin; Yujie Wan; Xingjie Du; Jian Li; Jun Wei; Ting Li; Chunhong Li; Zhongbing Liu; Meiling Zhou; Zhirong Zhong
Journal:  J Nanobiotechnology       Date:  2021-01-21       Impact factor: 10.435

6.  Elucidation of the Transport Mechanism of Puerarin and Gastrodin and Their Interaction on the Absorption in a Caco-2 Cell Monolayer Model.

Authors:  Li Jiang; Yanling Xiong; Yu Tu; Wentong Zhang; Qiyun Zhang; Peng Nie; Xiaojun Yan; Hongning Liu; Ronghua Liu; Guoliang Xu
Journal:  Molecules       Date:  2022-02-11       Impact factor: 4.411

Review 7.  Gastrodin and Vascular Dementia: Advances and Current Perspectives.

Authors:  Chujun Deng; Huize Chen; Zeyu Meng; Shengxi Meng
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-12       Impact factor: 2.650

8.  Assessment and characteristics of Erenumab therapy on migraine management.

Authors:  Haitham Saeed; Alaa S Tulbah; Amr Gamal; Marwa Kamal
Journal:  Saudi Pharm J       Date:  2022-06-22       Impact factor: 4.562

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.